Table 1.
Baseline Patient Characteristics (N = 56)
| Characteristic | No. | % |
|---|---|---|
| Age, years | ||
| Median | 65 | |
| Range | 41-82 | |
| Sex | ||
| Male | 38 | 68 |
| Female | 18 | 32 |
| Histologic subtype | ||
| Follicular lymphoma | 16 | 29 |
| CLL/SLL | 16 | 29 |
| Mantle-cell lymphoma | 9 | 16 |
| DLBCL | 7 | 13 |
| Marginal zone/mucosal-associated lymphoid tissue lymphoma | 4 | 7 |
| Waldenström macroglobulinemia | 4 | 7 |
| Prior therapy | ||
| Median No. | 3 | |
| Range | 1-10 | |
| Rituximab | 52 | 93 |
| Alkylator based | 47 | 84 |
| Anthracycline based | 25 | 45 |
| Radiotherapy | 15 | 27 |
| Autologous stem-cell transplantation | 3 | 5 |
Abbreviations: CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; SLL, small lymphocytic lymphoma.